Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Anemia

  Free Subscription


Articles published in Am J Kidney Dis

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    November 2017
  1. PAGE EE, Little DJ, Vesely SK, George JN, et al
    Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
    Am J Kidney Dis. 2017;70:686-695.
    PubMed     Text format     Abstract available


    August 2017
  2. DUINEVELD C, Verhave JC, Berger SP, van de Kar NCAJ, et al
    Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Am J Kidney Dis. 2017 Aug 16. pii: S0272-6386(17)30836.
    PubMed     Text format     Abstract available


    June 2017

  3. Erratum Regarding "Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD" (Am J Kidney Dis. 2017;69[6]:815-826).
    Am J Kidney Dis. 2017;69:869.
    PubMed     Text format    


    February 2017
  4. GUPTA N, Wish JB
    Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD.
    Am J Kidney Dis. 2017 Feb 24. pii: S0272-6386(17)30110.
    PubMed     Text format     Abstract available


    January 2017
  5. WINKELMAYER WC, Goldstein BA, Mitani AA, Ding VY, et al
    Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
    Am J Kidney Dis. 2017 Jan 4. pii: S0272-6386(16)30667.
    PubMed     Text format     Abstract available


  6. DEUX JF, Audard V, Brugieres P, Habibi A, et al
    Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
    Am J Kidney Dis. 2017;69:51-59.
    PubMed     Text format     Abstract available


    December 2016
  7. VIDAL E, van Stralen KJ, Chesnaye NC, Bonthuis M, et al
    Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.
    Am J Kidney Dis. 2016 Dec 9. pii: S0272-6386(16)30596.
    PubMed     Text format     Abstract available


    August 2016
  8. LUO J, Jensen DE, Maroni BJ, Brunelli SM, et al
    Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients.
    Am J Kidney Dis. 2016 Aug 12. pii: S0272-6386(16)30282.
    PubMed     Text format     Abstract available


    June 2016
  9. SHEPSHELOVICH D, Rozen-Zvi B, Avni T, Gafter U, et al
    Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis.
    Am J Kidney Dis. 2016 Jun 16. pii: S0272-6386(16)30125.
    PubMed     Text format     Abstract available


    April 2016
  10. RATCLIFFE LE, Thomas W, Glen J, Padhi S, et al
    Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale.
    Am J Kidney Dis. 2016;67:548-58.
    PubMed     Text format     Abstract available


    March 2016
  11. HABBIG S, Bergmann C, Weber LT
    Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome Due to a Mutation in CFH.
    Am J Kidney Dis. 2016;67:532-3.
    PubMed     Text format    


    February 2016
  12. PROVENZANO R, Besarab A, Wright S, Dua S, et al
    Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.
    Am J Kidney Dis. 2016 Feb 1. pii: S0272-6386(16)00005.
    PubMed     Text format     Abstract available


    January 2016
  13. BRIGANDI RA, Johnson B, Oei C, Westerman M, et al
    A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.
    Am J Kidney Dis. 2016 Jan 27. pii: S0272-6386(15)01495.
    PubMed     Text format     Abstract available


    December 2015
  14. LEE J, Imani P, Geer J, Braun M, et al
    The Pharmacokinetics of Intradialytic Administration of Eculizumab in an Infant.
    Am J Kidney Dis. 2015;66:1105-6.
    PubMed     Text format    


    November 2015
  15. VAZIRI ND, Kalantar-Zadeh K, Wish JB
    New Options for Iron Supplementation in Maintenance Hemodialysis Patients.
    Am J Kidney Dis. 2015 Nov 23. pii: S0272-6386(15)01322.
    PubMed     Text format     Abstract available


    September 2015
  16. BROOKHART MA, Freburger JK, Ellis AR, Winkelmayer WC, et al
    Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.
    Am J Kidney Dis. 2015 Sep 15. pii: S0272-6386(15)01061.
    PubMed     Text format     Abstract available


  17. BONOMINI M, Del Vecchio L, Sirolli V, Locatelli F, et al
    New Treatment Approaches for the Anemia of CKD.
    Am J Kidney Dis. 2015 Sep 12. pii: S0272-6386(15)01059.
    PubMed     Text format     Abstract available


    August 2015
  18. RIGOTHIER C, Delmas Y, Roumenina LT, Contin-Bordes C, et al
    Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAlambda Antibody.
    Am J Kidney Dis. 2015;66:331-6.
    PubMed     Text format     Abstract available


    July 2015
  19. ARDISSINO G, Possenti I, Tel F, Testa S, et al
    Discontinuation of eculizumab treatment in atypical hemolytic uremic syndrome: an update.
    Am J Kidney Dis. 2015;66:172-3.
    PubMed     Text format    


  20. WAGNER LA, Tata AL, Fink JC
    Patient safety issues in CKD: core curriculum 2015.
    Am J Kidney Dis. 2015;66:159-69.
    PubMed     Text format    


  21. WILHELM-LEEN ER, Winkelmayer WC
    Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.
    Am J Kidney Dis. 2015;66:69-74.
    PubMed     Text format     Abstract available


    June 2015
  22. BU F, Meyer NC, Zhang Y, Borsa NG, et al
    Soluble c5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome.
    Am J Kidney Dis. 2015;65:968-9.
    PubMed     Text format    


    May 2015
  23. NORIS M, Remuzzi G
    Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015.
    Am J Kidney Dis. 2015 May 29. pii: S0272-6386(15)00732.
    PubMed     Text format    


  24. WINKELMAYER WC, Chang TI, Mitani AA, Wilhelm-Leen ER, et al
    Longer-term Outcomes of Darbepoetin Alfa Versus Epoetin Alfa in Patients With ESRD Initiating Hemodialysis: A Quasi-experimental Cohort Study.
    Am J Kidney Dis. 2015 May 2. pii: S0272-6386(15)00532.
    PubMed     Text format     Abstract available


    April 2015
  25. FISHBANE S, Shah HH
    The emerging role of biosimilar epoetins in nephrology in the United States.
    Am J Kidney Dis. 2015;65:537-42.
    PubMed     Text format     Abstract available


    March 2015
  26. WARADY BA, Abraham AG, Schwartz GJ, Wong CS, et al
    Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.
    Am J Kidney Dis. 2015 Mar 12. pii: S0272-6386(15)00090.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: